HUP9701540A1 - A gasztrointesztinális keringést elősegítő gyógyászati készítmény - Google Patents
A gasztrointesztinális keringést elősegítő gyógyászati készítményInfo
- Publication number
- HUP9701540A1 HUP9701540A1 HU9701540A HUP9701540A HUP9701540A1 HU P9701540 A1 HUP9701540 A1 HU P9701540A1 HU 9701540 A HU9701540 A HU 9701540A HU P9701540 A HUP9701540 A HU P9701540A HU P9701540 A1 HUP9701540 A1 HU P9701540A1
- Authority
- HU
- Hungary
- Prior art keywords
- lower alkyl
- pharmaceutical composition
- blood circulation
- improving gastrointestinal
- gastrointestinal blood
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 230000017531 blood circulation Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000001624 naphthyl group Chemical group 0.000 abstract 2
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Az (I) általánős képletű vegyületek (mely képletben R1 jelentése a fenilgyűrűn adőtt esetben kis szénatőmszámúalkilcsőpőrttal, kis szénatőmszámú alkőxicsőpőrttal vagyhalőgénatőmmal helyettesített fenil-(kis szénatőmszámú alkil)-csőpőrtvagy naftil-(kis szénatőmszámú alkil)-csőpőrt; R2 jelentése hidrőgénatőm vagy biőlógiailag labilis észtert képezőcsőpőrt; és R3 jelentése hidrőgénatőm vagy biőlógiailag labilis észtert képezőcsőpőrt) és az (I) általánős képletű karbőnsavak gyógyászatilagalkalmas sói gasztrőintesztinális keringési zavarők kezelésére és/vagymegelőzésére alkalmas gyógyászati készítmények előállításáraalkalmazhatók. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19638020A DE19638020A1 (de) | 1996-09-18 | 1996-09-18 | Die gastrointestinale Durchblutung fördernde Arzneimittel |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9701540D0 HU9701540D0 (en) | 1997-10-28 |
HUP9701540A1 true HUP9701540A1 (hu) | 2000-08-28 |
HU223752B1 HU223752B1 (hu) | 2005-01-28 |
Family
ID=7805990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9701540A HU223752B1 (hu) | 1996-09-18 | 1997-09-15 | A gasztrointesztinális keringést elősegítő gyógyászati készítmény |
Country Status (6)
Country | Link |
---|---|
US (1) | US5783573A (hu) |
EP (1) | EP0830863B1 (hu) |
JP (1) | JP4204083B2 (hu) |
DE (2) | DE19638020A1 (hu) |
ES (1) | ES2145545T3 (hu) |
HU (1) | HU223752B1 (hu) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19906310A1 (de) * | 1999-02-16 | 2000-08-17 | Solvay Pharm Gmbh | Arzneimittel zur Behandlung von Bluthochdruck |
DE19932555A1 (de) * | 1999-07-13 | 2001-01-18 | Solvay Pharm Gmbh | Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen |
AU784327B2 (en) * | 1999-11-19 | 2006-03-09 | Abbvie B.V. | Human enzymes of the metalloprotease family |
AR039352A1 (es) * | 2001-05-18 | 2005-02-16 | Solvay Pharm Gmbh | Uso de un compuesto que tiene actividad inhibitoria combinada y concurrente con endopeptidasa neutra y metaloproteasa igs5. |
DE60234952D1 (de) * | 2001-09-10 | 2010-02-11 | Tibotec Pharm Ltd | VERFAHREN ZUR HERSTELLUNG VON HEXAHYDROFUROc2,3-BÜFURAN-3-OL |
EP1468010A1 (en) * | 2002-01-16 | 2004-10-20 | Solvay Pharmaceuticals B.V. | Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds |
AR038681A1 (es) * | 2002-02-14 | 2005-01-26 | Solvay Pharm Bv | Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua |
US6842358B2 (en) * | 2002-08-01 | 2005-01-11 | Netlogic Microsystems, Inc. | Content addressable memory with cascaded array |
US7045653B2 (en) * | 2002-12-23 | 2006-05-16 | Pfizer, Inc. | Pharmaceuticals |
US7262184B2 (en) | 2003-09-26 | 2007-08-28 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
US7452875B2 (en) | 2003-09-26 | 2008-11-18 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
US7427611B2 (en) | 2003-09-26 | 2008-09-23 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
WO2005049035A1 (en) * | 2003-11-18 | 2005-06-02 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients |
US20050267072A1 (en) * | 2004-05-14 | 2005-12-01 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions containing dually acting inhibitors of neutral endopeptidase for the treatment of sexual dysfunction |
US20050267124A1 (en) * | 2004-05-14 | 2005-12-01 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors |
US20050288272A1 (en) * | 2004-06-23 | 2005-12-29 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1 receptor antagonists |
BRPI0519919A2 (pt) | 2004-12-15 | 2009-04-07 | Solvay Pharm Gmbh | composições farmacêuticas compreendendo inibidores da nep, inibidores do sistema de produção de endotelina endógena e inibidores da hmg coa redutase |
US20060159748A1 (en) * | 2004-12-23 | 2006-07-20 | Rajesh Jain | Oral immediate release formulation of a poorly water-soluble active substance |
TW200633713A (en) * | 2004-12-23 | 2006-10-01 | Solvay Pharm Bv | Oral immediate release formulation of a poorly water-soluble active substance |
US20060205625A1 (en) * | 2005-02-18 | 2006-09-14 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics |
WO2007102171A2 (en) * | 2006-03-07 | 2007-09-13 | Panacea Biotec Ltd | Novel salts of 1h-1-benzazepine-1-acetic acid, their preparation and pharmaceutical composition |
US20070292503A1 (en) * | 2006-06-16 | 2007-12-20 | Gorissen Henricus R | Oral pharmaceutical composition of poorly water-soluble active substance |
US20070299054A1 (en) * | 2006-06-22 | 2007-12-27 | Rajesh Jain | Oral pharmaceutical composition of a poorly water-soluble active agent |
JP2012526810A (ja) | 2009-05-13 | 2012-11-01 | イントラ−セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
AR079059A1 (es) | 2009-12-07 | 2011-12-21 | Abbott Healthcare Products Bv | Acido ((3s)-3-(((1-(((2r)-2-carboxi-4-(1-naftil) butil) ciclopentil)-carbonil) amino )-2-oxo-2,3,4,5-tetrahidro-1h-1-benzazepin-1-il) acetico cristalino, su preparacion y uso |
WO2014127331A1 (en) | 2013-02-17 | 2014-08-21 | Intra-Cellular Therapies, Inc. | Novel uses |
JP6591530B2 (ja) | 2014-08-07 | 2019-10-16 | イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. | 有機化合物 |
CN105017154B (zh) * | 2015-07-07 | 2017-10-10 | 浙江博聚新材料有限公司 | 一种3‑溴‑1,3,4,5‑四氢‑2h‑1‑苯并氮杂卓‑2‑酮制备方法 |
WO2017136727A2 (en) | 2016-02-05 | 2017-08-10 | Denali Therapeutics Inc. | Compounds, compositions and methods |
WO2017172795A1 (en) | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel compositions and methods |
ES2912295T3 (es) | 2016-12-09 | 2022-05-25 | Denali Therapeutics Inc | Compuestos útiles como inhibidores de RIPK1 |
PL424453A1 (pl) * | 2018-01-31 | 2019-08-12 | Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością | Sposoby zmniejszania szkodliwego działania niedoboru perfuzji narządów miąższowych przez inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) |
JP7401442B2 (ja) | 2018-01-31 | 2023-12-19 | イントラ-セルラー・セラピーズ・インコーポレイテッド | 新規使用 |
TW202334164A (zh) | 2022-01-12 | 2023-09-01 | 美商戴納立製藥公司 | (S)-5-苄基-N-(5-甲基-4-側氧基-2,3,4,5-四氫吡啶並[3,2-b][1,4]氧氮呯-3-基)-4H-1,2,4-三唑-3-甲醯胺的晶型 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9310075D0 (en) * | 1993-05-17 | 1993-06-30 | Fujisawa Pharmaceutical Co | New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
DE19510566A1 (de) * | 1995-03-23 | 1996-09-26 | Kali Chemie Pharma Gmbh | Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
1996
- 1996-09-18 DE DE19638020A patent/DE19638020A1/de not_active Withdrawn
-
1997
- 1997-09-09 ES ES97115603T patent/ES2145545T3/es not_active Expired - Lifetime
- 1997-09-09 DE DE59701631T patent/DE59701631D1/de not_active Expired - Lifetime
- 1997-09-09 EP EP97115603A patent/EP0830863B1/de not_active Expired - Lifetime
- 1997-09-15 HU HU9701540A patent/HU223752B1/hu not_active IP Right Cessation
- 1997-09-15 US US08/929,114 patent/US5783573A/en not_active Expired - Lifetime
- 1997-09-17 JP JP25192897A patent/JP4204083B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
HU9701540D0 (en) | 1997-10-28 |
JPH10101565A (ja) | 1998-04-21 |
EP0830863B1 (de) | 2000-05-10 |
DE59701631D1 (de) | 2000-06-15 |
EP0830863A1 (de) | 1998-03-25 |
US5783573A (en) | 1998-07-21 |
JP4204083B2 (ja) | 2009-01-07 |
ES2145545T3 (es) | 2000-07-01 |
DE19638020A1 (de) | 1998-03-19 |
HU223752B1 (hu) | 2005-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9701540A1 (hu) | A gasztrointesztinális keringést elősegítő gyógyászati készítmény | |
FI870219A (fi) | Hypoglykemiska tiazolidindioner. | |
ATE326867T1 (de) | Freie aminosäure enthaltende zusammensetzung | |
FR2670491B1 (fr) | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
ATE325128T1 (de) | Substituierte aminoalkanphosphonsäuren | |
RU92016445A (ru) | Применение амидов изоксазол-4-карбоновой кислоты и амидов гидроксиалкилиденциануксусной кислоты | |
ATE52916T1 (de) | Zubereitungen zur behandlung von mycoplasmosen und bakteriellen erkrankungen bei gefluegel. | |
NO166939C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater. | |
DE68923151D1 (de) | Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen. | |
FI925801A0 (fi) | Piperidyl-substituerade indoler | |
MD382C2 (ro) | Procedeu de obţinere a piperazinilalchil-3(2H)-piridazinonelor sau a sărurilor lor farmaceutice admisibile | |
BG103207A (en) | Esters of the arylcycloalkanecarboxylic acids, their application, pharmaceutical compositions and their preparation | |
IS1771B (is) | Ný píperídín-4-karboxamíð sem hafa kvalastillandiog staðdeyfandi áhrif | |
KR910015300A (ko) | 부스피론 : 수면 무호흡증의 치료용도 | |
NO156900B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater. | |
DE3778642D1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
HUP9903679A2 (hu) | Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására | |
NO147877C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-oksazepin-derivater | |
ATE70440T1 (de) | Verwendung von anipamil als artereosklerosemittel. | |
EE02938B1 (et) | p-hüdroksübensoehappe derivaadid, nende valmistamismeetod ja kasutamine ravimitena | |
DE59105323D1 (de) | Neue Salze der 2-(2,6-Dichloranilino)-phenylessigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung für topisch anwendbare pharmazeutische Zubereitungen. | |
DK66384A (da) | 3-deazaguaninsulfonsyresalte | |
HUP9903928A2 (hu) | Fenoxi-etil-amin új származékai,eljárás előállításukra, alkalmazásuk gyógyszerhatóanyagokként és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
TH42244A (hu) | ||
DK0868181T3 (da) | Anvendelse af alfa,alfa-diphenyleddikesyre-4-(N-methyl-piperidyl)-estere som spasmoanalgetikum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HFG4 | Patent granted, date of granting |
Effective date: 20041122 |
|
MM4A | Lapse of definitive patent protection due to non-payment of fees |